logo

The Future of Dyne Therapeutics Inc: Analyzing DYN

In terms of market performance, Dyne Therapeutics Inc had a fairly even. The highest value for the stock in the past year was $30.27 on 03/01/24, and the lowest value was recorded at $6.40 on 10/30/23.

52-week price history of DYN Stock

Studying a stock’s 52-week price history, which includes both low and high prices, can help gauge its current status and potential future performance. Dyne Therapeutics Inc’s current trading price is -21.72% away from its 52-week high, while its distance from the 52-week low is 270.23%. The stock’s price range during the 52-week period has remained between $6.40 and $30.27. In the Healthcare sector, the company’s shares saw a trading volume of around 0.71 million for the day, which was evidently lower than the average daily volume of 1.41 million over the past three months.

Market Capitalization and Financial Performance: An In-Depth Look

Dyne Therapeutics Inc (DYN) has experienced a quarterly rise of 32.37% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 1.92B and boasts a workforce of 141 employees.

Making Sense of Trading Volume and Moving Average Data

Based on Barchart.com data, the company’s moving average over the 100-day period was 21.13, with a change in price of +12.61. Similarly, Dyne Therapeutics Inc recorded 1,712,037 in trading volume during the last 100 days, posting a change of +113.85%.

Examining DYN’s Debt-to-Equity Ratio: What You Need to Know

The debt-to-equity (D/E) ratio is a crucial measure that sheds light on a company’s financial health and market standing. It is determined by dividing a company’s overall liabilities by its shareholders’ equity, showing the extent of a company’s debt usage in financing its assets compared to the shareholders’ equity. At the time of writing, the total D/E ratio for DYN stands at 0.30. Similarly, the long-term debt-to-equity ratio is also 0.25.

DYN Stock Stochastic Average

Dyne Therapeutics Inc’s raw stochastic average for the past 50 days is presently 23.28%, as of today. This marks a increase from the raw stochastic average of the last 20 days, which was 9.93%. Additionally, the company’s Stochastic %K and %D values for the past 20 days were 24.24% and 26.02%, respectively.

DYN Stock Price Performance Analysis

The stock price’s performance over the year has been unpredictable, resulting in a mix of pessimistic and optimistic outlooks among investors. Until today this year the stock’s price performance recorded an increase of 78.16%. However, over the last six months, the performance has been weaker by 240.45%. The price of DYN decreased -11.52% over the last 30 days. And in the last five days, it has surged by 0.19%.

Most Popular